Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 55 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

11 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

11 recruiting1 with results

Enrollment Performance

Analytics

N/A
14(37.8%)
Phase 1
10(27.0%)
Phase 4
7(18.9%)
Phase 3
4(10.8%)
Phase 2
2(5.4%)
37Total
N/A(14)
Phase 1(10)
Phase 4(7)
Phase 3(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials
NCT07637877Phase 2Not Yet Recruiting

Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study

Role: collaborator

NCT07635355Not Yet Recruiting

Real-World Data Linkage Research Platform

Role: collaborator

NCT07544121Not ApplicableNot Yet Recruiting

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

Role: collaborator

NCT07481032Not ApplicableNot Yet Recruiting

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

Role: collaborator

NCT06253533Phase 1Completed

ICVAX as a HIV Therapeutic DNA Vaccine

Role: collaborator

NCT07422701Not Yet Recruiting

Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation

Role: collaborator

NCT06524427Not ApplicableRecruiting

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

Role: collaborator

NCT06905522Phase 3Recruiting

A PAN-USR TB Multi-Center Trial

Role: lead

NCT07232784Completed

Serial Measurement of Pancreatic Stone Protein (PSP) for Sepsis Early Detection in ICU Patients

Role: collaborator

NCT06085690Not ApplicableRecruiting

Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

Role: collaborator

NCT07120750Not Yet Recruiting

Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

Role: lead

NCT05939167Phase 1Recruiting

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

Role: collaborator

NCT07076225Phase 3Not Yet Recruiting

Ultra-Short Regimen for Elderly DS-TB

Role: lead

NCT07071636Phase 4Not Yet Recruiting

Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

Role: lead

NCT05847894Recruiting

Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology

Role: collaborator

NCT06975774Phase 1Completed

Phase II Clinical Clical of the Pure Protein Derivatives of BCG

Role: collaborator

NCT06930807Not ApplicableRecruiting

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Role: collaborator

NCT06916585Phase 2Not Yet Recruiting

Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients

Role: lead

NCT04538911Phase 1Active Not Recruiting

Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients

Role: collaborator

NCT06726356Not ApplicableRecruiting

Value of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis.

Role: collaborator